|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/28 | |
| A61P 3/10 |
| (11) | Patento numeris | 1802329 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05792052.2 |
| Europos patento paraiškos padavimo data | 2005-10-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-07-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-05-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2005/055017 |
| Data | 2005-10-05 |
| (87) | Numeris | WO 2006/037789 |
| Data | 2006-04-13 |
| (30) | Numeris | Data | Šalis |
| 200401519 | 2004-10-05 | DK |
| (72) |
BERGLUND, Petter, SE
HAMMELEV, Charlotte, DK
ESKILDSEN, Lone, DK
MADSEN, Johanne, DK
OLSEN, Helle, Aalund, DK
KIMER, Lone, L gstrup, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | A PHARMACEUTICAL FORMULATION COMPRISING CRYSTALLINE INSULIN AND DISSOLVED INSULIN |
| A PHARMACEUTICAL FORMULATION COMPRISING CRYSTALLINE INSULIN AND DISSOLVED INSULIN |